FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

772032008: Burosumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3708082013 Burosumab en Synonym Active Entire term case insensitive SNOMED CT core module
3708083015 Burosumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Burosumab Is a Monoclonal immunoglobulin G true Inferred relationship Existential restriction modifier
Burosumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing burosumab (medicinal product) Has active ingredient True Burosumab Inferred relationship Existential restriction modifier 1
Product containing burosumab in parenteral dose form (medicinal product form) Has active ingredient True Burosumab Inferred relationship Existential restriction modifier 1
Burosumab Has active ingredient True Burosumab Inferred relationship Existential restriction modifier 1
Product containing only burosumab in parenteral dose form (medicinal product form) Has active ingredient True Burosumab Inferred relationship Existential restriction modifier 1
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Burosumab Inferred relationship Existential restriction modifier 1
Product containing precisely burosumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Burosumab Inferred relationship Existential restriction modifier 1
Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Burosumab Inferred relationship Existential restriction modifier 1
Product containing precisely burosumab 30 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Burosumab Inferred relationship Existential restriction modifier 1
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Burosumab Inferred relationship Existential restriction modifier 1
Product containing precisely burosumab 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Burosumab Inferred relationship Existential restriction modifier 1
Burosumab 10mg/1ml solution for injection vials Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Burosumab 10mg/1ml solution for injection vials 1 vial Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Crysvita 10mg/1ml solution for injection vials (Kyowa Kirin Ltd) 1 vial Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Burosumab 30mg/1ml solution for injection vials Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Burosumab 20mg/1ml solution for injection vials 1 vial Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Crysvita 20mg/1ml solution for injection vials (Kyowa Kirin Ltd) 1 vial Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Burosumab 20mg/1ml solution for injection vials Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Crysvita 20mg/1ml solution for injection vials (Kyowa Kirin Ltd) Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Crysvita 30mg/1ml solution for injection vials (Kyowa Kirin Ltd) Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Burosumab 30mg/1ml solution for injection vials 1 vial Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Crysvita 10mg/1ml solution for injection vials (Kyowa Kirin Ltd) Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier
Crysvita 30mg/1ml solution for injection vials (Kyowa Kirin Ltd) 1 vial Has specific active ingredient True Burosumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start